These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 21206484)
21. Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region. Toth K; Kuppuswamy M; Doronin K; Doronina O; Lichtenstein D; Tollefson A; Wold W Virology; 2002 Sep; 301(1):99-108. PubMed ID: 12359450 [TBL] [Abstract][Full Text] [Related]
22. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses. Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160 [TBL] [Abstract][Full Text] [Related]
23. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Zsengeller ZK; Wert SE; Hull WM; Hu X; Yei S; Trapnell BC; Whitsett JA Hum Gene Ther; 1995 Apr; 6(4):457-67. PubMed ID: 7612702 [TBL] [Abstract][Full Text] [Related]
24. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Liu Q; Zaiss AK; Colarusso P; Patel K; Haljan G; Wickham TJ; Muruve DA Hum Gene Ther; 2003 May; 14(7):627-43. PubMed ID: 12804145 [TBL] [Abstract][Full Text] [Related]
25. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype. Mack CA; Song WR; Carpenter H; Wickham TJ; Kovesdi I; Harvey BG; Magovern CJ; Isom OW; Rosengart T; Falck-Pedersen E; Hackett NR; Crystal RG; Mastrangeli A Hum Gene Ther; 1997 Jan; 8(1):99-109. PubMed ID: 8989999 [TBL] [Abstract][Full Text] [Related]
26. Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity. Osada T; Yang XY; Hartman ZC; Glass O; Hodges BL; Niedzwiecki D; Morse MA; Lyerly HK; Amalfitano A; Clay TM Cancer Gene Ther; 2009 Sep; 16(9):673-82. PubMed ID: 19229288 [TBL] [Abstract][Full Text] [Related]
27. Germline incorporation of a replication-defective adenoviral vector in mice does not alter immune responses to adenoviral vectors. Camargo FD; Huey-Louie DA; Finn AV; Sassani AB; Cozen AE; Moriwaki H; Schneider DB; Agah R; Dichek DA Mol Ther; 2000 Nov; 2(5):496-504. PubMed ID: 11082323 [TBL] [Abstract][Full Text] [Related]